BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barreca ML, Manfroni G, Leyssen P, Winquist J, Kaushik-Basu N, Paeshuyse J, Krishnan R, Iraci N, Sabatini S, Tabarrini O, Basu A, Danielson UH, Neyts J, Cecchetti V. Structure-based discovery of pyrazolobenzothiazine derivatives as inhibitors of hepatitis C virus replication. J Med Chem 2013;56:2270-82. [PMID: 23409936 DOI: 10.1021/jm301643a] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Ahmad M, Aslam S, Rizvi SU, Muddassar M, Ashfaq UA, Montero C, Ollinger O, Detorio M, Gardiner JM, Schinazi RF. Molecular docking and antiviral activity of N-substituted benzyl/phenyl-2-(3,4-dimethyl-5,5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-2(4H)-yl)acetamides. Bioorg Med Chem Lett 2015;25:1348-51. [PMID: 25701249 DOI: 10.1016/j.bmcl.2015.01.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
2 Manfroni G, Cannalire R, Barreca ML, Kaushik-Basu N, Leyssen P, Winquist J, Iraci N, Manvar D, Paeshuyse J, Guhamazumder R, Basu A, Sabatini S, Tabarrini O, Danielson UH, Neyts J, Cecchetti V. The versatile nature of the 6-aminoquinolone scaffold: identification of submicromolar hepatitis C virus NS5B inhibitors. J Med Chem 2014;57:1952-63. [PMID: 24131104 DOI: 10.1021/jm401362f] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
3 Saddique FA, Zaib S, Jalil S, Aslam S, Ahmad M, Sultan S, Naz H, Iqbal M, Iqbal J. Synthesis, monoamine oxidase inhibition activity and molecular docking studies of novel 4-hydroxy-N'-[benzylidene or 1-phenylethylidene]-2-H/methyl/benzyl-1,2-benzothiazine-3-carbohydrazide 1,1-dioxides. Eur J Med Chem 2018;143:1373-86. [PMID: 29126721 DOI: 10.1016/j.ejmech.2017.10.036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
4 Manfroni G, Manvar D, Barreca ML, Kaushik-Basu N, Leyssen P, Paeshuyse J, Cannalire R, Iraci N, Basu A, Chudaev M, Zamperini C, Dreassi E, Sabatini S, Tabarrini O, Neyts J, Cecchetti V. New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors. J Med Chem 2014;57:3247-62. [PMID: 24654886 DOI: 10.1021/jm401688h] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
5 Neeraja P, Srinivas S, Banothu V, Sridhar B, Mukkanti K, Dubey PK, Pal S. Assembly of Benzothiazine and Triazole in a Single Molecular Entity: Synthesis of -Oxicam Derived Novel Molecules as Potential Antibacterial/ Anti-cancer Agents. Mini Rev Med Chem 2020;20:929-40. [PMID: 31976832 DOI: 10.2174/1389557520666200124091315] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Aslam S, Ahmad M, Zia-Ur-Rehman M, Montero C, Detorio M, Parvez M, Schinazi RF. Synthesis and anti-HIV-1 screening of novel N'-(1-(aryl)ethylidene)-2-(5,5-dioxido-3-phenylbenzo[e]pyrazolo[4,3-c][1,2]thiazin-4(1H)-yl)acetohydrazides. Arch Pharm Res 2014;37:1380-93. [PMID: 23835833 DOI: 10.1007/s12272-013-0200-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
7 Liu Y, Hu Y, Lv G, Nie R, Peng Y, Zhang C, Lv S, Hai L, Wang H, Wu Y. Synthesis of 1,2-Benzothiazines via C–H Activation/Cyclization in a Recyclable, Mild System. ACS Sustainable Chem Eng 2019;7:13425-9. [DOI: 10.1021/acssuschemeng.9b02803] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
8 Tarantino D, Cannalire R, Mastrangelo E, Croci R, Querat G, Barreca ML, Bolognesi M, Manfroni G, Cecchetti V, Milani M. Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor. Antiviral Res 2016;134:226-35. [PMID: 27649989 DOI: 10.1016/j.antiviral.2016.09.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
9 Lei K, Liu Y, Wang S, Sun B, Hua X, Xu X. Synthesis and Herbicidal Activity of 3-Acetyl-4-hydroxy-2,1-benzothiazine Derivatives. Chem Res Chin Univ 2019;35:609-15. [DOI: 10.1007/s40242-019-9029-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Khalid H, Landry KB, Ijaz B, Ashfaq UA, Ahmed M, Kanwal A, Froeyen M, Mirza MU. Discovery of novel Hepatitis C virus inhibitor targeting multiple allosteric sites of NS5B polymerase. Infect Genet Evol 2020;84:104371. [PMID: 32485331 DOI: 10.1016/j.meegid.2020.104371] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Barreca ML, Iraci N, Manfroni G, Gaetani R, Guercini C, Sabatini S, Tabarrini O, Cecchetti V. Accounting for Target Flexibility and Water Molecules by Docking to Ensembles of Target Structures: The HCV NS5B Palm Site I Inhibitors Case Study. J Chem Inf Model 2014;54:481-97. [DOI: 10.1021/ci400367m] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
12 Guerra WD, Lucena-Agell D, Hortigüela R, Rossi RA, Fernando Díaz J, Padrón JM, Barolo SM. Design, Synthesis, and in vitro Evaluation of Tubulin-Targeting Dibenzothiazines with Antiproliferative Activity as a Novel Heterocycle Building Block. ChemMedChem 2021. [PMID: 34231318 DOI: 10.1002/cmdc.202100383] [Reference Citation Analysis]
13 Saif MJ, Ahmad M, Idrees N. X-ray crystal and DFT study of a potent anti-HIV-1 agent: 2-(5,5-Dioxido-3-phenylpyrazolo[4,3-c][1,2]benzothiazin-4(2H)-yl)-N′-[(3-nitrophenyl)methylidene]acetohydrazide. J Theor Comput Chem 2016;15:1650038. [DOI: 10.1142/s0219633616500383] [Reference Citation Analysis]
14 Aslam S, Zaib S, Ahmad M, Gardiner JM, Ahmad A, Hameed A, Furtmann N, Gütschow M, Bajorath J, Iqbal J. Novel structural hybrids of pyrazolobenzothiazines with benzimidazoles as cholinesterase inhibitors. European Journal of Medicinal Chemistry 2014;78:106-17. [DOI: 10.1016/j.ejmech.2014.03.035] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
15 Sabatini S, Manfroni G, Barreca ML, Bauer SM, Gargaro M, Cannalire R, Astolfi A, Brea J, Vacca C, Pirro M, Massari S, Tabarrini O, Loza MI, Fallarino F, Laufer SA, Cecchetti V. The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors. Chem Biol Drug Des 2015;86:531-45. [DOI: 10.1111/cbdd.12516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
16 Zhao C, Wang Y, Ma S. Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors. Eur J Med Chem 2015;102:188-214. [PMID: 26276434 DOI: 10.1016/j.ejmech.2015.07.046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
17 Aslam S, Ahmad M, Athar MM, Ashfaq UA, Gardiner JM, Montero C, Detorio M, Parvez M, Schinazi RF. Synthesis, molecular docking and antiviral screening of novel N′-substitutedbenzylidene-2-(4-methyl-5,5-dioxido-3-phenylbenzo[e]pyrazolo[4,3-c][1,2]thiazin-1(4H)-yl)acetohydrazides. Med Chem Res 2014;23:2930-46. [DOI: 10.1007/s00044-013-0879-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Lei K, Hua X, Tao Y, Liu Y, Liu N, Ma Y, Li Y, Xu X, Kong C. Discovery of (2-benzoylethen-1-ol)-containing 1,2-benzothiazine derivatives as novel 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibiting-based herbicide lead compounds. Bioorganic & Medicinal Chemistry 2016;24:92-103. [DOI: 10.1016/j.bmc.2015.11.032] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
19 de Macedo MB, Kimmel R, Urankar D, Gazvoda M, Peixoto A, Cools F, Torfs E, Verschaeve L, Lima ES, Lyčka A, Milićević D, Klásek A, Cos P, Kafka S, Košmrlj J, Cappoen D. Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones. Eur J Med Chem 2017;138:491-500. [PMID: 28689097 DOI: 10.1016/j.ejmech.2017.06.061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
20 Zhou Z, Zhang J, Zhou E, Ren C, Wang J, Wang Y. Small molecule NS5B RdRp non-nucleoside inhibitors for the treatment of HCV infection: A medicinal chemistry perspective. Eur J Med Chem 2022;240:114595. [PMID: 35868125 DOI: 10.1016/j.ejmech.2022.114595] [Reference Citation Analysis]
21 Gannarapu MR, Vasamsetti SB, Punna N, Kotamraju S, Banda N. Synthesis of novel 1-substituted triazole linked 1,2-benzothiazine 1,1-dioxido propenone derivatives as potent anti-inflammatory agents and inhibitors of monocyte-to-macrophage differentiation. Med Chem Commun 2015;6:1494-500. [DOI: 10.1039/c5md00171d] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
22 Manvar D, Pelliccia S, La Regina G, Famiglini V, Coluccia A, Ruggieri A, Anticoli S, Lee JC, Basu A, Cevik O, Nencioni L, Palamara AT, Zamperini C, Botta M, Neyts J, Leyssen P, Kaushik-Basu N, Silvestri R. New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2. Eur J Med Chem 2015;90:497-506. [PMID: 25483263 DOI: 10.1016/j.ejmech.2014.11.042] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
23 Ahmad S, Jalil S, Zaib S, Aslam S, Ahmad M, Rasul A, Arshad MN, Sultan S, Hameed A, Asiri AM, Iqbal J. Synthesis, X-ray crystal and monoamine oxidase inhibitory activity of 4,6-dihydrobenzo[c]pyrano[2,3-e][1,2]thiazine 5,5-dioxides: In vitro studies and docking analysis. Eur J Pharm Sci 2019;131:9-22. [PMID: 30735822 DOI: 10.1016/j.ejps.2019.02.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
24 Shao N, Chen T, Zhang T, Zhu H, Zheng Q, Zou H. Cascade regioselective synthesis of pyrazoles from nitroallylic acetates and N-tosyl hydrazine. Tetrahedron 2014;70:795-9. [DOI: 10.1016/j.tet.2013.12.046] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
25 Dang P, Zheng Z, Liang Y. Copper-Catalyzed C(sp 3 )–S Bond and C(sp 2 )–S Bond Cross-Coupling of 2-(2-Iodobenzoyl) Substituted or 2-(2-Iodobenzyl) Substituted 1,2,3,4-Tetrahydroisoquinolines with Potassium Sulfide: Synthesis of Isoquinoline-Fused 1,3-Benzothiazine Scaffolds. J Org Chem 2017;82:2263-8. [DOI: 10.1021/acs.joc.6b02943] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
26 Abid SMA, Aslam S, Zaib S, Bakht SM, Ahmad M, Athar MM, Gardiner JM, Iqbal J. Pyrazolobenzothiazine-based carbothioamides as new structural leads for the inhibition of monoamine oxidases: design, synthesis, in vitro bioevaluation and molecular docking studies. Medchemcomm 2017;8:452-64. [PMID: 30108763 DOI: 10.1039/c6md00570e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 2.6] [Reference Citation Analysis]
27 Ashraf A, Ejaz SA, Rahman SU, Siddiqui WA, Arshad MN, Lecka J, Sévigny J, Zayed MEM, Asiri AM, Iqbal J, Hartinger CG, Hanif M. Hybrid compounds from chalcone and 1,2-benzothiazine pharmacophores as selective inhibitors of alkaline phosphatase isozymes. European Journal of Medicinal Chemistry 2018;159:282-91. [DOI: 10.1016/j.ejmech.2018.09.063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Swaroop DK, Kumar NR, Ratnakarreddy K, Raja G, Srigiridhar K, Poornachandra Y, Kumar CG, Babu NJ, Kumar GS, Narsaiah B. Novel 1,2,3-Triazole-Functionalized 1,2-Benzothiazine 1,1-Dioxide Derivatives: Regioselective Synthesis, Biological Evaluation and Docking Studies. ChemistrySelect 2018;3:2398-403. [DOI: 10.1002/slct.201800072] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]